Muramaki Mototsugu, Hara Isao, Miyake Hideaki, Yamada Yuji, Kawabata Gaku, Kamidono Sadao
Division of Urology, Department of Organs Therapeutics, Faculty of Medicine, Kobe University Graduate School of Medicine, Kobe, Japan.
Int J Urol. 2005 Sep;12(9):855-8. doi: 10.1111/j.1442-2042.2005.01158.x.
Late relapse of germ cell tumors has been considered rare. We report six patients treated at our institution with relapses of germ cell tumors more than 2 years after first successful management. Median time to late relapse for pure seminomas and non-seminomatous germ cell tumors was 30.0 and 75.5 months, respectively. The sites of the late relapses in two cases of pure seminoma were located out of the fields of irradiation. After systematic chemotherapy, both these patients remain disease free. Two patients with non-seminomatous germ cell tumors received salvage chemotherapy at the time of late relapse, but tumor markers did not normalize in either case. A complete resection of relapsed masses was performed in three cases of non-seminomatous germ cell tumors. All three patients are without evidence of disease. The incidence of late relapse in patients with pure seminomas and non-seminomas was 2.4% and 3.3%, respectively, which suggests the necessity for long-term follow up.
生殖细胞肿瘤的晚期复发一直被认为较为罕见。我们报告了在我院接受治疗的6例患者,他们在首次成功治疗后2年以上出现生殖细胞肿瘤复发。纯精原细胞瘤和非精原细胞性生殖细胞肿瘤的晚期复发中位时间分别为30.0个月和75.5个月。2例纯精原细胞瘤晚期复发的部位位于放疗野之外。经过系统化疗,这2例患者均无疾病迹象。2例非精原细胞性生殖细胞肿瘤患者在晚期复发时接受了挽救性化疗,但两例患者的肿瘤标志物均未恢复正常。3例非精原细胞性生殖细胞肿瘤患者对复发肿块进行了完整切除。所有3例患者均无疾病证据。纯精原细胞瘤和非精原细胞瘤患者的晚期复发率分别为2.4%和3.3%,这表明有必要进行长期随访。